BioXcel Therapeutics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
BioXcel Therapeutics, Inc. (BTAI) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $52.11 million as of 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Balance Sheet
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2018-05-14
- 2018-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $52.11M.
- 2017-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$982.00K.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2018-03-31 | $52.11M 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$982.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |